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Abstract
Background: Analysis of gene expression data in terms of a priori-defined gene sets has recently received
significant attention as this approach typically yields more compact and interpretable results than those produced
by traditional methods that rely on individual genes. The set-level strategy can also be adopted with similar
benefits in predictive classification tasks accomplished with machine learning algorithms. Initial studies into the
predictive performance of set-level classifiers have yielded rather controversial results. The goal of this study is to
provide a more conclusive evaluation by testing various components of the set-level framework within a large
collection of machine learning experiments.
Results: Genuine curated gene sets constitute better features for classification than sets assembled without
biological relevance. For identifying the best gene sets for classification, the Global test outperforms the gene-set
methods GSEA and SAM-GS as well as two generic feature selection methods. To aggregate expressions of genes
into a feature value, the singular value decomposition (SVD) method as well as the SetSig technique improve on
simple arithmetic averaging. Set-level classifiers learned with 10 features constituted by the Global test slightly
outperform baseline gene-level classifiers learned with all original data features although they are slightly less
accurate than gene-level classifiers learned with a prior feature-selection step.
Conclusion: Set-level classifiers do not boost predictive accuracy, however, they do achieve competitive accuracy if
learned with the right combination of ingredients.
Availability: Open-source, publicly available software was used for classifier learning and testing. The gene
expression datasets and the gene set database used are also publicly available. The full tabulation of experimental
results is available at http://ida.felk.cvut.cz/CESLT.
Background
Set-level techniques have recently attracted significant
attention in the area of gene expression data analysis
[1-7]. Whereas in traditional analysis approaches one
typically seeks individual genes differentially expressed
across sample classes (e.g. cancerous vs. control), in the
set-level approach one aims to identify entire sets of
genes that are significant, e.g. in the sense that they
contain an unexpectedly large number of differentially
expressed genes. The gene sets considered for signifi-
cance testing are defined prior to analysis, using appro-
priate biological background knowledge. For example, a
defined gene set may contain genes acting in a given
cellular pathway or annotated by a specific term of the
gene ontology. The main advantage brought by set-level
analysis is the compactness and improved interpretability
of analysis results due to the smaller number of the set-
level units compared to the number of genes, and more
background knowledge available to such units. Indeed, the
long lists of differentially expressed genes characteristic of
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traditional expression analysis are replaced by shorter lists
of more informative units corresponding to actual biologi-
cal processes.
Predictive classification [8] is a form of data analysis
going beyond the mere identification of differentially
expressed units. Here, units deemed significant for the
discrimination between sample classes are assembled
into formal models prescribing how to classify new sam-
ples that contain yet unknown class labels. Predictive
classification techniques are thus especially relevant to
diagnostic tasks and as such have been explored since
very early studies on microarray data analysis [9]. Pre-
dictive models are usually constructed by supervised
machine learning algorithms [8,10] that automatically
discover patterns among samples with already available
labels (so-called training samples). Learned classifiers
may take diverse forms ranging from geometrically con-
ceived models such as Support Vector Machines [11],
which have been especially popular in the gene expres-
sion domain, to symbolic models such as logical rules or
decision trees that have also been applied in this area
[12-14].
The combination of set-level techniques with predic-
tive classification has been suggested [7,15,16] or applied
in specific ways [4,17-20] in previous studies, however, a
focused exploration of the strategy has commenced only
recently [21,22].
The set-level framework is adopted in predictive classifi-
cation as follows. Sample features originally bearing the
(normalized) expressions of individual genes are replaced
by features corresponding to gene sets. Each such feature
aggregates the expressions of the genes contained in the
corresponding set into a single real value; in the simplest
case, it may be the average expression of the contained
genes. The expression samples are then presented to the
learning algorithm in terms of these derived, set-level fea-
tures. The main motivation for extending the set-level fra-
mework to the machine learning setting is again the
interpretability of results. Informally, classifiers learned
using set-level features acquire forms such as “predict can-
cer if pathway P1 is active and pathway P2 is not” (where
activity refers to aggregated expressions of the member
genes). In contrast, classifiers learned in the standard set-
ting derive predictions from expressions of individual
genes; it is usually difficult to find relationships among the
genes involved in such a classifier and to interpret the
latter in terms of biological processes.
Lifting features to the set level incurs a significant com-
pression of the training data since the number of consid-
ered gene sets is typically much smaller than the number
of interrogated genes. This compression raises the natural
question whether relevant information is lost in the trans-
formation, and whether the augmented interpretability
will be outweighed by compromised predictive accuracy.
On the other hand, reducing the number of sample fea-
tures may mitigate the risk of overfitting and thus, conver-
sely, contribute to higher accuracy. In machine learning
terms, reformulation of data samples through set-level fea-
tures increases the bias and decreases the variance of the
learning process [8]. An objective of this study is to assess
experimentally the combined effect of the two antagonistic
factors on the resulting predictive accuracy.
Another aspect of transforming features to the set level
is that biological background knowledge is channeled into
learning through the prior definitions of biologically plau-
sible gene sets. Among the goals of this study is to assess
how significantly such background knowledge contributes
to the performance of learned classifiers. We do this
assessment by comparing classification accuracy achieved
with genuine curated gene sets against that obtained with
gene sets identical to the latter in number and sizes, yet
lacking any biological relevance. We also investigate pat-
terns distinguishing genuine gene sets particularly useful
for classification from those less useful.
A further objective is to evaluate–from the machine
learning perspective–statistical techniques proposed
recently in the research on set-level gene expression analy-
sis. These are the Gene Set Enrichment Analysis (GSEA)
method [1], the SAM-GS algorithm [3] and a technique
known as the Global test [2]. Informally, they rank a given
collection of gene sets according to their correlation with
phenotype classes. The methods naturally translate into
the machine learning context in that they facilitate feature
selection [23], i.e. they are used to determine which gene
sets should be provided as sample features to the learning
algorithm. We experimentally verify whether these meth-
ods work reasonably in the classification setting, i.e.
whether learning algorithms produce better classifiers
from gene sets ranked high by the mentioned methods
than from those ranking lower. We investigate classifica-
tion conducted with a single selected gene set as well as
with a batch of high ranking sets. Furthermore, we test
how the three gene-set-specific methods compare to some
generic feature selection heuristics (information gain and
support vector machine with recursive feature extraction)
known from machine learning.
To use a machine learning algorithm, a unique value
for each feature of each training sample must be estab-
lished. Set-level features correspond to multiple expres-
sions and these must therefore be aggregated. We
comparatively evaluate three aggregation options. The
first (AVG) simply averages the expressions of the
involved genes. The value assigned to a sample and a
gene set is independent of other samples and classes. The
other two, more sophisticated, methods (SVD, SetSig)
rely respectively on the singular value decomposition
principle [7] and the so-called gene set signatures [22]. In
the latter two approaches, the value assigned to a given
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sample and a gene set depends also on expressions mea-
sured in other samples. Let us return to the initial experi-
mental question concerned with how the final predictive
accuracy is influenced by the training data compression
incurred by reformulating features to the set level. As fol-
lows from the above, two factors contribute to this com-
pression: selection (not every gene from the original
sample representation is a member of a gene set used in
the set-level representation, i.e. some interrogated genes
become ignored) and aggregation (for every gene set in
the set-level representation, expressions of all its mem-
bers are aggregated into a single value). We quantify the
effects of these factors on predictive accuracy. Regarding
selection, we experiment with set-level representations
based on 10 best gene sets and 1 best gene set, respec-
tively, with both numbers chosen ad-hoc. The two
options are applied with all three selection methods
(GSEA, SAM-GS, Global). We compare the obtained
accuracy to the baseline case where all individual genes
are provided as features to the learning algorithm, and to
an augmented baseline case where a prior feature-selec-
tion step is taken using the information gain heuristic.
For each of the selection cases, we further evaluate the
contribution of the aggregation factor. This evaluation is
done by comparing all the three aggregation mechanisms
(AVG, SVD, SetSig) to the control case where no aggre-
gation is performed at all; in this case, individual genes
combined from the selected gene groups act as features.
The key contribution of the present study is thus a
thorough experimental evaluation of a number of aspects
and methods of the set-level strategy employed in the
machine learning context, entailing the reformulation of
various, independently published relevant techniques
into a unified framework. Such a contribution is impor-
tant both due to the current state of the art in microarray
data analysis, wherein according to the review [24], the
need for thoroughly evaluating existing techniques
currently seems to outweigh the need to develop new tech-
niques, and specifically due to the inconclusive results of
previous, less extensive studies indicating both superior-
ity (e.g. [20]) and inferiority (Section 4 in [22]) of the set-
level approach to classificatory machine learning, with
respect to the accuracy achievable by the baseline gene-
level approach.
Our contributions are, however, also significant
beyond the machine learning scope. In the general area
of set-level expression analysis, it is undoubtedly impor-
tant to establish a performance ranking of the various
statistical techniques for the identification of significant
gene sets in class-labeled expression data. This is made
difficult by the lack of an unquestionable ranking criter-
ion–there is in general no ground truth stipulating
which gene sets should indeed be identified by the
tested algorithms. The typical approach embraced by
comparative studies such as [3] is thus to appeal to
intuition (e.g. the p53 pathway should be identified in
p53-gene mutation data). However legitimate such argu-
ments are, evaluations based on them are obviously lim-
ited in generality and objectivity. We propose that the
predictive classification setting supported by the cross-
validation procedure for unbiased accuracy estimation,
as adopted in this paper, represents exactly such a
needed framework enabling objective comparative
assessment of gene set selection techniques. In this fra-
mework, results of gene set selection are deemed good
if the selected gene sets allow accurate classification of
new samples. Through cross-validation, the accuracy
can be estimated in an unbiased manner.
Main results
We first verified whether gene sets ranked high by the
established set-level analysis methods (GSEA, SAM-GS,
Global) indeed lead to construction of better classifiers by
machine learning algorithms, i.e. we investigated how clas-
sification accuracy depends on Factor 3 in Table 1. In the
top panel of Figure 1, we plot the average accuracy for
Factor 3 alternatives ranging 1 to 10 (top 10 gene sets),
and n − 9 to n (bottom 10). The trend line fitted by the
least squares method shows a clear decay of accuracy as
lower-ranking sets are used for learning. The bottom
panel corresponds to Factor 3 values 1:10 (left) and n − 9 :
n (right) corresponding to the situations where the 10 top-
ranking and the 10 bottom-ranking (respectively) gene
sets are combined to produce a feature set for learning.
Again, the dominance of the former in terms of accuracy
is obvious.
Given the above, there is no apparent reason why low-
ranking gene sets should be used in practical experi-
ments. Therefore, to maintain relevance of the subse-
quent conclusions, we conducted further analyses on
Table 1 Factors
Analyzed factors Alternatives #Alts
1. Gene sets (Sec.) Genuine, Random 2
2. Ranking algo (Sec.) GSEA, SAM-GS, Global 3
3. Set(s) forming features* 1, 2, ... 10,n - 9, n - 8,...n,1:10, n - 9 : n 22
4. Aggregation (Sec.) SVD, AVG, SetSig, None 4
Product 528
Auxiliary factors Alternatives #Alts
5. Learning algo (Sec.) svm, 1-nn, 3-nn, nb, dt 5
6. Dataset (Sec.) d1 ... d30 30
7. Testing Fold f1 ... f10 10
Product 1500
Alternatives considered for factors influencing the set-level learning workflow.
The number left of each factor refers to the workflow step (Fig. 2) in which it
acts.
*Identified by rank, n corresponds to the lowest ranking set, i:j denotes that
all of gene sets ranking i to j are used to form features.
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the set-level experimental sample only with measure-
ments where Factor 3 (gene set rank) is either 1 or 1:10.
We next addressed the hypothesis that genuine gene
sets constitute better features than random gene sets, i.
e. we investigated the influence of Factor 1 in Table 1.
Classifiers learned with genuine gene sets exhibited sig-
nificantly higher predictive accuracies (p = 1.4 × 10−4,
one-sided test) than those based on random gene sets.
Given this result, there is a clear preference to use
genuine gene sets over random gene sets in practical
applications. Once again, to maintain relevance of our
subsequent conclusions, we constrained further analyses
of the set-level sample to measurements conducted with
genuine gene sets.
Working now with classifiers learned with high-ranking
genuine gene sets, we revisited Factor 3 to assess the dif-
ference between the remaining alternatives 1 and 1:10
corresponding respectively to more and less compression
of training data. The 1:10 variant where sample features
capture information from the ten best gene sets exhibits
significantly (p = 3.5 × 10−5) higher accuracy than the 1
variant using only the single best gene set to constitute
features (that is, a single feature if aggregation is
employed).
We further compared the three dedicated gene-set
ranking methods, i.e. evaluated the effect of Factor 2 in
Table 1. Since three comparisons are conducted in this
case (one per pair), we used the Bonferroni-Dunn
adjustment on the Wilcoxon test result. The Global test
turned out to exhibit significantly higher accuracy than
either SAM-GS (p = 0.0051) or GSEA (p = 0.0039). The
difference between the latter two methods was not
significant.
Concerning the aggregation method (Factor 4 in
Table 1), there are two questions of interest: whether
there are significant differences in the performance of
Figure 1 Accuracy decay. The top panels show the plots for the average accuracy of Factor 3 alternatives ranging 1 to 10, and n−9 to n.
Average predictive accuracy tends to fall as lower-ranking gene sets are used to constitute features (see text for details). The trend lines shown
in the top panels are the ones minimizing the residual least squares. The bottom panel gives the accuracy boxplot for the batch experiments. 10
highest-ranking and the 10 lowest-ranking (respectively) gene sets are combined to produce a feature set for learning. Again, the dominance of
the former in terms of accuracy is obvious. Each point in the top panels and each box plot in the bottom panel follows from 16,000 learning
experiments.
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the individual aggregation methods (SVD, AVG, SetSig),
and whether aggregation in general has a detrimental
effect on performance. As for the first question, both
SVD and SetSig proved to outperform AVG (p = 0.011
and p = 0.03, respectively), while the difference between
SVD and SetSig is insignificant. The answer to the sec-
ond question turned out to depend on Factor 3 as fol-
lows. In the more compressive (1) alternative, the
answer is affirmative in that all the three aggregation
methods result in less accurate classifiers than those not
involving aggregation (p = 0.0061 for SVD, p = 0.013
for SetSig and p = 1.1 × 10−4 for AVG, all after Bonfer-
roni-Dunn adjustment).
However, the detrimental effect of aggregation tends to
vanish in the less compressive (1:10) alternative of Factor
3, where only the AVG alternative in comparison to
None yields a significant difference (p = 0.011). Table 2
summarizes the main findings presented above.
The principal trends can also be well observed
through the ranked list of methodological combinations
by median classification accuracy, again generated from
measurements not involving random or low-ranking
gene sets. This is shown in Table 3. Position 17 refers
to the baseline method where sample features capture
expressions of all genes and prior gene set definitions
are ignored. In agreement with the statistical conclu-
sions above, the ranked table clearly indicates the super-
iority of the Global test for gene-set ranking, and of
using the 10 best gene sets (i.e., the 1:10 alternative) to
establish features rather than relying only on the single
best gene set. It is noteworthy that all four combinations
involving the Global test and the 1:10 alternative (i.e.,
ranks 1, 2, 4, 5) outperform the baseline method.
While intuitive, rankings based on median accuracy
over multiple datasets may, according to [25], be proble-
matic as to their statistical reliability. Therefore, we offer
in Table 4 an alternative ranking of the 19 methods that
avoids mixtures of predictive accuracies from different
datasets. Here, the methods were sub-ranked on each of
the 150 combinations of 30 datasets and 5 learning algo-
rithms by cross-validated predictive accuracy achieved on
that combination. The 150 sub-ranks were then averaged
for each method, and this average dictates the ranking
shown in the table. In this ranking, the baseline strategy
improves its rank to Position 5. The superiority of classi-
fiers learned from 10 gene sets selected by the Global
test, as formerly noted for Table 3, continues to hold in
the alternative ranking underlying Table 4.
Additional analyses
Generic feature selection
In the set-level classification framework, gene sets play
the role of sample features. Therefore the three gene-set
ranking methods (GSEA, SAM-GS, Global) are employed
for feature selection conducted in the learning workflow.
While the latter three methods originate from research
on gene expression analysis, generic feature selection
methods have also been proposed in machine learning
research [23]. It is interesting to compare the latter to the
gene-expression-specific methods. To this end, we
Table 2 Summary of results
Factor Alternatives
Better Worse
1. Gene sets Genuine Random
2. Ranking algo Global SAM-GS, GSEA
3. Sets forming
features
high ranking, 1:10 (best ten
sets)
low ranking, 1 (best
set)
4. Aggregation* SetSig, SVD AVG
See Section Main Results for details on how the conclusions were determined.
*Difference not significant if Factor 3 is 1:10.
Table 3 Ranking of gene set methods
Rank Methods Accuracy
Sets Rank. Algo Aggrgt Median Avg s Iqr
1 1:10 Global SVD 89.2 79.5 18.9 33.2
2 1:10 Global None 88.3 81.0 17.7 31.3
3 1 Global None 87.8 80.7 17.5 31.0
4 1:10 Global SetSig 87.4 81.1 16.5 26.1
5 1:10 Global AVG 85.6 78.7 18.4 32.6
6 1:10 SAM-GS SetSig 85.4 79.9 17.1 30.2
7 1:10 SAM-GS None 84.6 80.1 17.3 30.7
8 1 Global SVD 83.8 77.9 20.1 34.3
9 1:10 GSEA SetSig 83.4 78.3 16.7 26.3
10 1:10 GSEA None 82.3 80.0 16.8 30.4
11 1:10 SAM-GS SVD 79.9 77.1 18.0 32.1
12 1:10 GSEA SVD 79.2 77.2 17.7 31.7
13 1:10 GSEA AVG 79.1 76.4 16.9 31.9
14 1 SAM-GS None 78.3 76.0 15.3 26.3
15 1 Global SetSig 77.5 75.9 15.1 23.5
16 1 GSEA None 76.7 75.6 16.3 29.5
17 baseline (all genes used) 75.5 76.6 18.4 33.5
18 1 SAM-GS SetSig 75.0 74.7 14.2 18.9
19 1 Global AVG 72.7 73.8 17.6 31.1
20 1:10 SAM-GS AVG 72.5 73.8 15.9 26.0
21 1 GSEA SetSig 70.2 72.6 17.0 26.8
22 1 GSEA AVG 69.6 68.1 12.8 22.4
23 1 GSEA SVD 69.5 71.9 16.3 28.2
24 1 SAM-GS SVD 69.0 69.5 15.7 21.3
25 1 SAM-GS AVG 67.3 67.0 11.4 15.5
Ranking of combinations of gene set methods by median predictive accuracy
achieved on 30 datasets (Table 8, Section Expression and gene sets) with 5
machine learning algorithms (Section Machine learning) estimated through 10-
fold cross-validation (i.e. 1,500 experiments per row). The columns indicate,
respectively, the resulting rank by median accuracy, the gene sets used to
form features (1 - the top ranking set, 1:10 - the top ten ranking sets), the
gene set selection method, the expression aggregation method (see Section
Methods and data for details on the latter 3 factors), and the median, average,
standard deviation and interquartile range of the accuracy.
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consider two approaches. Information Gain (IG) [10] is a
feature-selection heuristic popular in machine learning.
In brief, IG measures the expected reduction in class-
entropy caused by partitioning the given sample set by
the values of the assessed feature. One of the main disad-
vantages of IG is that it disregards potential feature inter-
actions. Support Vector Machine with Recursive Feature
Extraction (SVM-RFE) [26] is a method that ranks fea-
tures by repetitive training of a SVM classifier with a lin-
ear kernel while gradually removing the feature with the
smallest input classifier weight. This approach does not
assume that features are mutually independent. On the
other hand, it naturally tends to select a feature set that
maximizes the accuracy of the specific kind of classifier
(SVM). For computational reasons (large number of runs
and genes), we removed several features at a time (F × 2
−i features in the i-th iteration, where F is the original
number of features). [26] mentions such a modification
with the caveat that it may be at the expense of possible
classification performance degradation.
In the present context, generic feature selection can be
applied either on the gene level or on the set level. We
explored both scenarios.
The gene-level application produces a variant of the
baseline classifier (position 17 in Table 3, position 5 in
Table 4) where, however, the learning algorithm only
receives features corresponding to genes top-ranked by
the feature selection heuristic, rather than all measured
genes. The selection is thus based only on the predictive
power of the individual genes and ignores any prior
definitions of gene sets. The question of how many top-
ranking genes should be used for learning is addressed
as follows. We want to make the resulting predictive
accuracy comparable to that obtained in the main (set-
level) experimental protocol, in particular to the 1 and
1:10 alternatives of Factor 3. The median of the number
of unique genes present in the selected gene sets in the
1 (1:10, respectively) alternative is 22 (228). Therefore
we experiment respectively with 22 and 228 genes top-
ranked by generic feature selection. The results are
shown in Table 5. Comparing the latter to Tables 3 and
4, we observe that both variants improve the baseline
and in fact produce the most accurate classifiers (IG
outperforms the set-level approaches, SVM-RFE is com-
parable with the Global test). SVM-RFE does not out-
perform IG in general, but it does so in the special case
when SVM is used as the learning algorithm.
While the gene-level application of feature selection
results in accurate classifiers, the obvious drawback of
this approach is that the genes referred in such pro-
duced classifiers cannot be jointly characterized by a
biological concept. This deficiency is removed if feature
selection is instead applied on the set level, i.e. to rank
apriori-defined gene sets. This way, the selection meth-
ods essentially become the fourth and fifth alternative of
Factor 2 (see Table 1) up to the following nuance.
While the dedicated gene-set methods (GSEA, SAM-GS,
Global) score a feature (gene set) by the expressions of
its multiple member genes, IG and SVM-RFE score a
feature by the single real value assigned to it, i.e., by the
aggregated expressions of the member genes. Therefore,
Table 4 Ranking of all combinations of methods
Rank Methods Avg Subrank
Sets Rank. algo Aggrgt
1 1:10 Global None 15.3
2 1:10 Global SetSig 15.7
3 1 Global None 16.3
4 1:10 GSEA None 16.7
5 baseline (all genes used) 16.8
6 1:10 Global SVD 17.0
7 1:10 SAM-GS None 17.2
8 1:10 SAM-GS SetSig 17.6
9 1:10 Global AVG 18.6
10 1 Global SVD 19.4
11 1:10 GSEA SetSig 19.9
12 1:10 GSEA SVD 20.1
13 1:10 SAM-GS SVD 20.8
14 1:10 GSEA AVG 22.1
15 1 Global SetSig 22.2
16 1 SAM-GS None 23.0
17 1 SAM-GS SetSig 23.8
18 1 GSEA None 23.9
19 1 Global AVG 24.6
20 1:10 SAM-GS AVG 25.5
21 1 GSEA SVD 26.7
22 1 GSEA SetSig 26.8
23 1 SAM-GS SVD 28.3
24 1 SAM-GS AVG 30.3
25 1 GSEA AVG 30.9
Ranking of all combinations of methods in terms of average subrank.
Subranking is done on each of the 150 combinations of 30 datasets and 5
learning algorithms by cross-validated predictive accuracy. Column
descriptions are as in Table 3.
Table 5 Generic feature selection (gene-level)
# Method # Selected Genes Accuracy Avg Subrank
Median Avg s Iqr
IG 22 90.2 81.5 18.1 30.7 15.0
IG 228 89.8 82.0 17.9 30.3 14.5
SVM-RFE 228 88.3 82.3 16.7 28.5 16.4
SVM-RFE 22 88.0 82.1 17.2 30.4 16.2
Performance of the baseline classification method equipped with a feature-
selection step prior to learning. Features (genes) are ranked by the
information gain and SVM-RFE heuristics. The number of selected top-ranking
genes (22 and 228, respectively) corresponds to the mean number of unique
genes acting in gene sets selected in the 1 and 1:10 (respectively) alternatives
of the set-level workflow.
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when using the generic feature selection, the aggregation
step in the experimental workflow (Figure 2) must pre-
cede the ranking step. The results of applying IG and
SVM-RFE on the set level are shown in Table 6. Com-
paring again to Tables 3 and 4, both IG and SVM-RFE
are outperformed by the Global test (Wilcoxon test, p =
0.017).
Successful gene sets
We also explored patterns distinguishing gene sets parti-
cularly useful for classification from other employed
gene sets sourced from the Molecular Signatures Data-
base. To this end, we defined three groups of gene sets.
The first group referred to as full comprises the entire
collection of 3028 gene sets obtained from the database
(gene sets containing fewer than 5 or more than 200
genes were discarded). The second group referred to as
selected consists of the 900 gene sets ranked high (1st to
10th) by any of the three selection methods for any of
the dataset. The third group referred to as successful is a
subset of the selected group and contains the 210 gene
sets acting in classifiers that outperformed the baseline.
We investigated two kinds of properties of the gene
sets contained in the three respective groups. First, we
considered the gene set type as defined in the Molecular
Figure 2 Workflow. The workflow of a set-level learning experiment conducted multiple times with varying alternatives in the numbered steps.
For compatibility with the learned classifier, testing fold samples are also reformulated to the set level. The reformulation is done using gene
sets selected in Step 3 and aggregation algorithm used in Step 4. The diagram abstracts from this operation.
Table 6 Generic feature selection (set-level)
Sets Methods Accuracy Avg Subrank
Selection Aggrgt Median Avg s Iqr
1:10 SVM-RFE SVD 88.3 80.6 17.3 33.0 17.6
1:10 IG SVD 87.0 79.0 18.7 31.6 17.4
1:10 IG AVG 84.6 78.2 18.6 33.4 18.7
1:10 SVM-RFE AVG 84.4 79.2 17.1 31.2 19.2
1:10 SVM-RFE SetSig 82.5 78.7 17.0 31.2 19.4
1 IG SVD 80.8 76.3 17.7 33.1 22.5
1:10 IG SetSig 80.0 77.1 17.4 33.2 20.8
1 SVM-RFE SetSig 71.8 73.7 15.8 26.4 23.3
1 SVM-RFE SVD 71.5 74.4 17.4 30.3 23.0
1 IG AVG 70.9 74.0 18.6 33.1 24.1
1 SVM-RFE AVG 70.8 72.5 15.4 26.6 24.4
1 IG SetSig 66.2 68.8 16.2 25.0 28.9
Performance of the set level classification strategy using the information gain
and SVM-RFE heuristics for ranking gene sets. Column descriptions are as in
Table 3.
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Signatures Database. The gene sets belonging to the
category of chemical and genetic perturbations (CGP)
were more frequently selected and also more frequently
appeared in the successful group than the gene sets
representing canonical pathways (CP) (full: CGPs 73%,
CPs 27%, selected: CGPs 88%, CPs 12%, successful:
CGPs 88%, CPs 12%). Second, we considered four possi-
ble notions of gene set size: i) nominal size (the gene set
cardinality), ii) effective size (number of genes from the
gene set measured in the dataset), iii) number of PCA
coefficients capturing 50% of expression variance in the
gene set, iv) as in iii) but with 90% variance. As follows
from Table 7, the successful group contains smaller gene
sets than the other two groups, and this trend is most
pronounced for the Global test ranking method (Mann-
Whitney U test, the successful group versus the full
group, Bonferroni adjustment: Effective size p = 0.084,
PCA 90% p = 0.0039).
Conclusions and discussion
Set-level approaches to gene expression data analysis
have proliferated in the last years, evidence of which are
both theoretical studies [1,2] and software tools with set-
level functionalities [27] such as enrichment analysis. The
added insight and augmented interpretability of analysis
results are the main reasons for the popularity of the set-
level framework. For the same reasons, the framework
has recently been also explored in the context of predic-
tive classification of gene expression data through
machine learning [4,17-22]. Conclusions of such studies
have however been rather limited as to the range of clas-
sification problems considered and techniques used in
the set-level machine learning workflow, and inconclu-
sive as to the statistical performance of set-level classi-
fiers. To this end, we have presented a large experimental
study, in which we formalized the mentioned set-level
workflow, identified various independently published
techniques relevant to its individual steps, and reformu-
lated them into a unified framework. By executing var-
ious instantiations of the workflow on 30 gene expression
classification problems, we have established the following
main conclusions.
1. State-of-the-art gene set ranking methods (GSEA,
SAM-GS, Global test) perform sanely as feature selec-
tors in the machine learning context in that high
ranking gene sets outperform (i.e., constitute better
features for classification than) those low ranking.
2. Genuine curated gene sets from the Molecular
Signature Database outperform randomized gene
sets. Smaller gene sets and sets pertaining to chemi-
cal and genetic perturbations were particularly
successful.
3. For gene set selection, the Global test [2] outper-
forms each of SAM-GS [3], GSEA [1] as well as the
generic information gain heuristic [10] and the
SVM-based recursive feature elimination approach
[26].
4. For aggregating expressions of set member genes
into a unique feature value, both SVD [7] and SetSig
[22] outperform arithmetic averaging [4].
5. Using top ten gene sets to construct features
results in better classifiers than using only the single
best gene set.
6. The set-level approach using top ten genuine gene
sets as ranked by the Global test outperforms the
baseline gene-level method in which the learning
algorithm is given access to expressions of all mea-
sured genes. However, it is outperformed by the
baseline approach if the latter is equipped with a
prior feature selection step.
Conclusion 1 is rather obvious and was essentially
meant as a prior sanity check.
Table 7 Comparison of the full, selected and successful group of gene sets
Group Selection Statistic Nominal size Effective size PCA 50% var PCA 90% var
Full None mean 71.7±1.7 40.9±0.7 4.4±0.03 16.7±0.14
median 37.0 28.1 4.1 15.3
Selected all mean 62.5±2.7 47.8±1.9 3.8±0.08 15.1±0.35
median 33.5 27.0 3.4 13.4
Global median 32.0 25.5 3.3 12.8
GSEA median 34.0 27.0 3.4 13.7
SAM-GS median 40.5 28.0 3.7 14.3
Successful all mean 56.9±4.4 39.2±2.9 4.3±0.14 14.7±0.56
median 31.0 21.0 3.9 12.6
Global median 22.0 18.5 3.8 11.7
GSEA median 37.0 27.5 4.3 14.2
SAM-GS median 30.5 22.5 4.0 12.7
Mean and median sizes of gene sets partitioned into three groups (see Section Successful gene sets for details.)
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The first statement of Conclusion 2 is not obvious,
since constructing randomized gene sets in fact corre-
sponds to the machine learning technique of stochastic
feature extraction [28] and as such may itself contribute
to learning good classifiers. Nevertheless, relevant back-
ground knowledge resting in the prior definition of bio-
logically plausible gene sets contributes further to
increasing the predictive accuracy. Conclusions 3 and 4
are probably the most significant for practitioners in
set-level predictive modeling of gene expression as so
far there has been no clear guidance to choose from the
two triples of methods.
Concerning Conclusion 3, the advantages of the Glo-
bal test were argued in [2] but not supported in terms
of the predictive power of the selected gene sets. As for
conclusion 4, the SetSig technique was introduced and
tested in [22], appearing superior to both averaging and
a PCA-based method which is conceptually similar to
the SVD method [7]. However, owing to the limited
experimental material in [22], the ranking was not con-
firmed by a statistical test. Here we confirmed the
superiority of SetSig with respect to averaging, however,
the difference of in the performance of SetSig and SVD
was not significant.
A further remark concerns the mentioned aggregation
methods. All three of them are applicable to any kind of
gene sets, whether these are derived from pathways,
gene ontology or other sources of background knowl-
edge. The downside of this generality is that substantial
information available for specific kinds of gene sets is
ignored. Of relevance to pathway-based gene sets, the
recent study [29] convincingly argues that the perturba-
tion of a pathway depends on the expressions of its
member genes in a non-uniform manner. It also pro-
poses how to quantify the impact of each member gene
on the perturbation, given the graphical structure of the
pathway. It seems reasonable that a pathway-specific
aggregation method should also weigh member genes by
their estimated impact on the pathway. Such a method
would likely result in more informative pathway-level
features and could outperform the three aggregation
methods we have considered.
Conclusion 5 is not entirely surprising. Relying only
on a single gene set entails too large an information loss
and results in classifiers less accurate than those using
ten best gene sets. Note that in the single gene set case,
when aggregation is applied (i.e., Factor 4 in Table 1 is
other than None, see the first example in Figure 3), the
sample becomes represented by only a single real-valued
feature and learning essentially reduces to finding a
threshold value for it. To verify that more than one
gene set should be taken into account, we tested the 10-
best-sets option and indeed it performed better.
Obviously, the optimal number of sets to be considered
depends on the particular classification problem and
data, and in practice it can be estimated empirically, e.g.
through internal cross-validation. Here, training data T
would be randomly split into a validation set V and the
remainder T’ = T \ V , e.g. with the 20%-80% propor-
tion. Classifiers would first be learned with T’, each with
a different value for the number of gene sets forming
features; this number could range e.g. as f Î {2, 4, 8,...,
128}. The number f* yielding the classifier most accurate
on the validation set V is then an estimate of the opti-
mal number of features. The final classifier would then
be learned on the entire training set T, using f* features.
While we could not follow this procedure due to com-
putational considerations (the already high number of
learning sessions would have grown excessively), it is a
reasonable instrument in less extensive experiments
such as in single-domain classification.
A straightforward interpretation of Conclusion 6 is
that the set-level framework is not an instrument for
boosting predictive accuracy. However, set-level classi-
fiers have a value per se, just as set-level units are useful
in standard differential analysis of gene expression data.
In this light, it is important that with a suitable choice
of techniques, set-level classifiers do achieve accuracy
competitive with conventional gene-level classifiers.
Methods and data
Here we first describe the methods adopted for gene set
ranking, gene expression aggregation, and for classifier
learning. Next we present the datasets used as bench-
marks in the comparative experiments. Lastly, we
describe the protocol followed by our experiments.
Gene set ranking
Three methods are considered for ranking gene sets. As
inputs, all of the methods take a set G = {g1, g2,...gp} of
interrogated genes, and a set S of N expression samples
where for each si Î S, si = (e1,i, e2,i,...ep,i) Î R
p where ej,i
denotes the (normalized) expression of gene gj in sample
si. The sample set S is partitioned into phenotype classes
S = C1∪C2∪...∪Co so that Ci∩Cj={} for i ≠ j. To simplify
this paper, we assume binary classification, i.e. o = 2. A
further input is a collection of gene sets G such that for
each  ∈ G it holds Γ ⊆ G. In the output, each of the
methods ranks all gene sets in G by their estimated
power to discriminate samples into the predefined
classes.
Next we give a brief account of the three methods and
refer to the original sources for a more detailed descrip-
tion. In experiments, we used the original implementa-
tions of the procedures as provided or published by the
respective authors.
Gene Set Enrichment Analysis (GSEA) [1] tests a
null hypothesis that gene rankings in a gene set Γ,
Holec et al. BMC Bioinformatics 2012, 13(Suppl 10):S15
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according to an association measure with the phenotype,
are randomly distributed over the rankings of all genes.
It first sorts G by correlation with binary phenotype.
Then it calculates an enrichment score (ES) for each
 ∈ G by walking down the sorted gene list, increasing a
running-sum statistic when encountering a gene gi Î Γ
and decreasing it otherwise. The magnitude of the
change depends on the correlation of gi with the pheno-
type. The enrichment score is the maximum deviation
from zero encountered in the random walk. It corre-
sponds to a weighted Kolmogorov-Smirnov-like statistic.
The statistical significance of the ES is estimated by an
empirical phenotype-based permutation test procedure
that preserves the correlation structure of the gene
expression data. GSEA was one of the first specialized
gene-set analysis techniques. It has been reported to
attribute statistical significance to gene sets that have no
gene associated with the phenotype, and to have less
power than other recent test statistics [2,3].
SAM-GS [3]
This method tests a null hypothesis that the mean vec-
tors of the expressions of genes in a gene set do not dif-
fer by phenotype. Each sample si is viewed as a point in
an N -dimensional Euclidean space. Each gene set  ∈ G
defines its |Γ|-dimensional subspace in which projec-
tions si of samples si are given by coordinates corre-
sponding to genes in Γ. The method judges a given by
how distinctly the clusters of points {si |si ∈ C1} and
{sj |sj ∈ C2} are separated from each other in the sub-
space induced by Γ. SAM-GS measures the Euclidean
distance between the centroids of the respective clusters
and applies a permutation test to determine whether,
and how significantly, this distance is larger than that
obtained if samples were assigned to classes randomly.
The Global Test [2]
The global test, analogically to SAM-GS, projects the
expression samples into subspaces defined by gene sets
 ∈ G. In contrast to the Euclidean distance applied in
SAM-GS, it proceeds instead by fitting a regression
function in the subspace, such that the function value
acts as the class indicator. The degree to which the two
clusters are separated then corresponds to the magni-
tude of the coefficients of the regression function.
Expression aggregation
Three methods are considered for assigning a value to a
given gene set Γ for a given sample si by aggregation of
expressions of genes in Γ.
Averaging (AVG)
The first method simply produces the arithmetic average
of the expressions ej,i of all Γ genes 1 ≤ j ≤ p in sample
si. The value assigned to the pair (si, Γ) is thus indepen-
dent of samples sj, i ≠ j.
Singular Value Decomposition (SVD)
A more sophisticated approach was employed by [7].
Here, the value assigned to (si, Γ) depends on
Figure 3 Examples of sample representation. Examples of sample representation generated with four combinations of alternatives of factors
3 and 4 from Table 1. Shown for one sample (i.e. header + one row) with eji denoting the expression of the i-th member of the j-ranked gene
set Γj. Non-exemplified combinations of the two factors are analogical to the cases shown. The remaining considered factors do not influence
the structure of sample representation.
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expressions ej,i measured in sample si but, unlike in the
averaging case, also on expressions ej,k measured in sam-
ples sk, k ≠ i. In particular, all samples in the sample set
S are viewed as points in the |Γ|-dimensional Euclidean
space induced by Γ the same way as explained in Sec-
tion Gene set ranking. Subsequently, the specific vector
in the space is identified, along which the sample points
exhibit maximum variance. Each point sk Î S is then
projected onto this vector. Finally, the value assigned to
(si, Γ) is the real-valued position of the projection of si
on the maximum-variance vector in the space induced
by Γ.
Gene Set Signatures (SetSig)
Similarly to the SVD method, the SetSig [22] method
assigns to (si, Γ) a value depending on expressions both
in sample si as well as in other samples sk, k ≠ i. However,
unlike in the previous two aggregation methods, here the
value also depends on the class memberships of these
samples. In particular, SetSig confines to two-class pro-
blems and the value (’signature’) assigned to (si, Γ) can be
viewed as the Student’s unpaired t-statistic for the means
of two populations of the Pearson correlation coeffi-
cients. The first (second) population studies correlation
of si with the samples from the first (second) class in the
space induced by Γ. Intuitively, the signature is positive
(negative) if the sample correlates rather with the sam-
ples belonging to the first (second) class.
Machine learning
We experimented with five diverse machine learning algo-
rithms to avoid dependence of experimental results on a
specific choice of a learning method. These algorithms are
explained in depth for example by [8]. In experiments, we
used the implementations available in the WEKA software
due to [30], using the default settings. None of the meth-
ods below is in principle superior to the others, although
the first one prevails in predictive modeling of gene
expression data and is usually associated with high resis-
tance to noise in data.
Support Vector Machine
Samples are viewed as points in a vector space with coor-
dinates given by the values of its features. A classifier is
sought in the form of a hyperplane that separates training
samples of distinct classes and maximizes the distance to
the points nearest to the hyperplane (i.e. maximizing the
margin) in that space or in a space of extended dimension
into which the original vector space is non-linearly
projected.
1-Nearest Neighbor
This algorithm is a simple form of classification pro-
ceeding without learning a formal data model. A new
sample is always predicted to have the same class as the
most similar sample (i.e. the nearest neighbor) available
in training data. We use the Euclidean metric to mea-
sure the similarity of two samples.
3-Nearest Neighbors
This method is similar to 1-Nearest Neighbor, except
that class is determined as one prevailing among the
three, rather than one, most similar samples in training
data. This method becomes superior to the previous one
as noise in data exceeds a certain threshold amount.
The threshold value (and thus the optimal number of
considered neighbors) is in general not known.
Naive Bayes
A sample is classified into the class that is most probable
given the sample’s feature values, according to a condi-
tional probability distribution learned from training data
on the simplifying assumption that, within each class, all
features are mutually independent random variables.
Gene expression data usually deviate from this assump-
tion and consequently the method becomes suboptimal.
Decision Tree
A tree-graph model enables to derive a class prediction
for a sample by following a path from the root to a leaf
of the tree, where the path is determined by outcomes
of tests on the values of features specified in the internal
nodes of the tree. The tree model is learned from train-
ing data and can also be represented as a set of decision
rules.
Expression and gene sets
We conducted our experiments using 30 public gene
expression datasets, each containing samples categorized
into two classes. This collection contains both hard and
easy classification problems (see Figure 4). The indivi-
dual datasets are listed in Table 8 and annotated in
more detail in the supplemental material at http://ida.
felk.cvut.cz/CESLT.
Besides expression datasets, we utilized a gene set data-
base consisting of 3272 manually curated sets of genes
obtained from the Molecular Signatures Database
(MSigDB v3.0) [1]. These gene sets have been compiled
from various online databases (e.g. KEGG, GenMAPP,
BioCarta).
For control experiments, we also prepared another
collection of gene sets that is identical to the latter in
the number of contained sets and the distribution of
their cardinalities. However, the contained sets are
assembled from random genes and have no biological
significance. The particular method used to obtain the
randomized gene sets is as follows. For sampling, we
consider the set Σ of all genes occurring in some of the
genuine gene sets, formally  = {g|g ∈ , ∈ G}. Then,
for each genuine gene set Γ, we sample |Γ| genes with-
out replacement uniformly from Σ to constitute the
counterpart random gene set Γ’.
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Experimental protocol
Classifier learning in the set-level framework follows a
simple workflow. Its performance is influenced by
several factors, each corresponding to a particular choice
from a class of techniques (such as for gene set rank-
ing). We evaluate the contribution that these factors
Figure 4 Histograms of differential gene expression. Histograms of differential gene expression suggest the difficulty of the individual
domains. An easy domain is supposed to have a strongly left-skewed histogram, while the difficult domains rather show a flat histogram. There
is one plot for each of 30 domains, x axis shows the p-value of differential expression, the y axis gene frequency.
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make to the predictive accuracy of the resulting classi-
fiers by repeated executions of the learning workflow
with varying the factors.
The learning workflow is shown in Figure 2. Given a
set of binary-labeled training samples from an expression
dataset, the workflow starts by ranking the provided col-
lection of a priori-defined gene sets according to their
power to discriminate sample classes. The resulting
ranked list is subsequently used to select the gene sets
which form set-level sample features. Each such feature
is then assigned a value for each training sample by
aggregating the expressions in the gene set corresponding
to the feature. An exception to this pattern is the None
alternative of the aggregation factor, where expressions
are not aggregated, and features correspond to genes
instead of gene sets. This alternative is considered for
comparative purposes. Figure 3 illustrates the resulting
sample representation for four combinations of the selec-
tion and aggregation alternatives. Next, a machine learn-
ing algorithm produces a classifier from the reformulated
training samples. Finally, the classifier’s predictive accu-
racy is calculated as the proportion of samples correctly
classified on an independent testing sample fold. For
compatibility with the learned classifier, the testing sam-
ples are also reformulated to the set level prior to testing,
using the same selected gene sets and aggregation
mechanism as in the training phase.
Seven factors along the workflow influence its result.
The alternatives considered for each of them are summar-
ized in Table 1. We want to assess the contributions of the
first four factors (top in table). The remaining three auxili-
ary factors (bottom in table) are employed to diversify the
experimental material and thus increase the robustness of
the findings. Factor 7 (testing fold) is involved automati-
cally through the adoption of the 10-fold cross-validation
procedure (see e.g. chap. 7 in [8]). We execute the work-
flow for each possible combination of factor alternatives,
obtaining a factored sample of 792,000 predictive accuracy
values.
While the measurements provided by the above protocol
allow us to compare multiple variants of the set-level fra-
mework for predictive classification, we also want to com-
pare these to the baseline gene-level alternative usually
adopted in predictive classification of gene expression
data. Here, each gene interrogated by a microarray repre-
sents a feature. This sample representation is passed
directly to the learning algorithm without involving any of
the pre-processing factors (1-4 in Table 1). The baseline
results are also collected using the 5 different learning
algorithms, the 30 benchmark datasets and the 10-fold
cross-validation procedure (i.e. Factors 5-7 in Table 1 are
employed). As a result, an additional sample of 1,500 pre-
dictive accuracy values is collected for the baseline variant.
Finally, to comply with the standard application of the
cross-validation procedure, we averaged the accuracy
values corresponding to the 10 cross-validation folds for
each combination of the remaining factors. The subse-
quent statistical analysis thus deals with a sample of
79,200 and 150 measurements for the set-level and base-
line experiments, respectively, described by the predictive
accuracy value and the values of the relevant factors.
All statistical tests conducted were based on the
paired Wilcoxon test (two-sided unless stated other-
wise). For pairing, we always related two measurements
equal in terms of all factors except for the one investi-







Adenocarcinoma 14023 8 29 GDS2201 [31]
ALL/AML 10056 24 24 Broad
institute
[32]
Brain/muscle 13380 41 20 - [4]
Breast tumors 14023 16 27 GDS1329 [33]
Clear cell sarcoma 14023 18 14 GDS1282 [34]
Colitis and Crohn 1 14902 42 26 GDS1615 [35]
Colitis and Crohn 2 14902 42 59 GDS1615 [35]
Colitis and Crohn 3 14902 26 59 GDS1615 [35]
Diabetes 13380 17 17 Broad
institute
[5]
Heme/stroma 13380 18 33 - [4]
Gastric cancer 5664 8 22 GDS1210 [36]
Gender 15056 15 17 Broad
institute
[1]
Gliomas 14902 26 59 GDS1975 [37]
Gliomas 2 31835 23 81 GDS1962 [38]










14023 90 97 GDS2771 [41]
Melanoma 14902 18 45 GDS1375 [42]
p53 10101 33 17 Broad
institute
[1]
Parkinson 1 14902 22 33 GDS2519 [43]
Parkinson 2 14902 22 50 GDS2519 [43]
Parkinson 3 14902 33 50 GDS2519 [43]
Pheochromocytoma 14023 38 37 GDS2113 [44]
Pleural mesothelioma 14902 10 44 GDS1220 [45]
Pollution 37804 88 41 - [46]
Prostate cancer 14023 18 45 GDS1390 [47]
Sarcoma and hypoxia 14902 15 39 GDS1209 [48]
Smoking 5664 18 26 GDS2489 [49]
Squamous-cell
carcinoma
9460 22 22 GDS2520 [50]
Testicular seminoma 9460 22 14 GDS2842 [51]
Number of genes interrogated and number of samples in each of the two
classes of each dataset.
Holec et al. BMC Bioinformatics 2012, 13(Suppl 10):S15
http://www.biomedcentral.com/1471-2105-13-S10-S15
Page 13 of 15
predictive accuracy samples in literature but our preli-
minary normality tests did not justify its application.
Given the extent of the collected samples, the Wilcoxon
test was sufficient to support the conclusions reported.
Besides, the Wilcoxon test is argued [25] to be statisti-
cally safer than the t-test for comparing classification
algorithms over multiple data sets.
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